Vaccine Market
Segments - by Types (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines, Conjugate Vaccines, and Subunit Vaccines), Applications (Infectious Diseases, Cancer, Autism, and Allergy), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global vaccine market size is anticipated to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising awareness of vaccination and high demand for better healthcare infrastructure.
Vaccines are also called as immunizations. Vaccine is an attenuated form of an infective organism, which is injected to a person to enhance immunity or antibodies against the disease. The use of vaccination has eliminated the chance of developing a number of diseases and even eradicated some of diseases such as smallpox and polio. Immunization plays a vital role to increase the quality of life of people by providing protection against various disease. The demand for immunization gained significant demand over the recent years, which is attributed to rise in prevalence of both bacterial and viral infectious diseases. Vaccinations are injected to people of various age groups, which brace the immune system for complete life span as well as provide protection against several infectious diseases.
As per several research studies, vaccination has prevented around 2 million people from succumbed to different diseases such as measles, tetanus, influenza, pertussis, diphtheria, and others. Additionally, according to the World Health Organization (WHO), more than 1.5 million deaths are estimated to be possible to be prevented, due to the advancement in global immunization coverage.
The COVID-19 pandemic outbreak caused most of the pharmaceutical, biotechnology, and healthcare organizations to focus on safety wearable, diagnostics kits, vaccines, and drugs for Novel coronavirus treatment. The major players in the market started to concentrate on developing vaccine for coronavirus. Furthermore, the healthcare professionals are busy in COVID-19 related services. The pharmaceutical organizations are focusing on research & development of COVID-19 related vaccines, treatments, diagnostics, and health technologies. All these factors are expected to drive the global vaccines market during the forecast period.
Market Trends, Drivers, Restraints, and Opportunities
- High prevalence of deadly infectious diseases across the world and increasing research & development activities in the field of vaccines are propelling the market growth.
- Increased government initiatives for the vaccination of the population is boosting the market growth.
- Introduction of highly efficient vaccines in preventing diseases is a key driver of the vaccine market
- Heavy research cost for development of vaccine and longtime durations are major restraints that can hamper the market growth in the near future.
- Occurrence of more deadly diseases and infectious diseases such as COVID-19 have increased the demand for vaccine development. This proves a huge opportunity of the global market at a significant rate.
Scope of the Report
The report on the global vaccine market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Vaccine Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines, Conjugate Vaccines, and Subunit Vaccines) and Applications (Infectious Diseases, Cancer, Autism, and Allergy) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Merck &Co., Inc.; Emergent BioSolutions, Inc.; Johnson and Johnson; Sanofi Pasteur, Inc.; Pfizer, Inc.; Novartis AG; CSL Ltd.; GlaxoSmithKline Plc.; Abbott Laboratories, Inc.; AstraZeneca Plc; Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals Company Ltd.; and Valeant Pharmaceuticals International, Inc. |
Market Segment Insights
Inactivated vaccines segment is expected to exhibit substantial growth
Based on the types, the global vaccine market is divided into live toxoid vaccines, attenuated vaccines, inactivated vaccines, DNA vaccines, conjugate vaccines, and subunit vaccines. The inactivated vaccines segment is expected to exhibit substantial growth during the projected period owing to the great stability and long shelf-life with high efficacy of the vaccine type. However, the DNA vaccine segment is expected to grow at an impressive growth rate in the coming years due to its reduced risk of integration and high specificity. The development of different vaccines and its high demand as well as various drugs under the pipeline are bolstering the market segment.
Infectious disease segment is projected to expand at a considerable CAGR
On the basis of applications, the market is segregated into infectious diseases, cancer, autism, and allergy. The infectious disease segment is projected to expand at a considerable CAGR during the forecast period attributed to high prevalence of infectious diseases and rising concerns about the vaccination among the population. Moreover, high frequency of diseases such as hepatitis, cholera, chickenpox, measles, typhoid, and others are major factors for this segment development. The extensive research activities for the disease control and prevention has resulted into large number of potential candidates for vaccine. The COVID-19 has also boosted the segment as many companies invested hugely for this vaccine development.
Cancer segment, however, is anticipated to register a substantial growth rate during the projected period as cancer is highly prevalent disease globally. As per several reports from organizations such as WHO, the number of the population suffering from cancer is going to increase continuously in the future.
North America is anticipated to constitute a major market share
In terms of regions, the global vaccine market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a major market share in the coming years owing to the well-developed healthcare infrastructure as well as presence of skilled professionals in the region. Moreover, huge investment by some of the major market players in the region is boosting the regional market expansion.
The market of Asia Pacific, however, is anticipated to grow at a robust pace in the forecast period attributed to the presence of a large number of untapped population in the region. Furthermore, growing disposable income and increasing awareness about the vaccine benefits among a huge population group in the region are estimated to spur the regional market expansion in the coming future.
Segments
Segments Covered in the Report
The global vaccine market has been segmented on the basis of
Types
- Live Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Infectious Diseases
- Cancer
- Autism
- Allergy
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Merck &Co., Inc.
- Emergent BioSolutions, Inc.
- Johnson and Johnson
- Sanofi Pasteur, Inc.
- Pfizer, Inc.
- Novartis AG
- CSL Ltd.
- GlaxoSmithKline Plc.
- Abbott Laboratories, Inc.
- AstraZeneca Plc
- Janssen Pharmaceuticals, Inc.
- Takeda Pharmaceuticals Company Ltd.
- Valeant Pharmaceuticals International, Inc.
Competitive Landscape
The key players of the global vaccine market are Merck &Co., Inc.; Emergent BioSolutions, Inc.; Johnson and Johnson; Sanofi Pasteur, Inc.; Pfizer, Inc.; Novartis AG; CSL Ltd.; GlaxoSmithKline Plc.; Abbott Laboratories, Inc.; AstraZeneca Plc; Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals Company Ltd.; and Valeant Pharmaceuticals International, Inc. AstraZeneca collaborated with the University of Oxford to develop the COVID-19 vaccine in 2020 in an attempt to curb the spread of the pandemic.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vaccine Market - Supply Chain
4.5. Global Vaccine Market Forecast
4.5.1. Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vaccine Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Vaccine Market Absolute $ Opportunity
5. Global Vaccine Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Vaccine Market Size and Volume Forecast by Types
5.3.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Vaccine Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Vaccine Market Size and Volume Forecast by Applications
6.3.1. Infectious Diseases Cancer Autism Allergy
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Vaccine Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Vaccine Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Vaccine Demand Share Forecast, 2019-2026
8. North America Vaccine Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Vaccine Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Vaccine Market Size and Volume Forecast by Types
8.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Vaccine Market Size and Volume Forecast by Applications
8.7.1. Infectious Diseases Cancer Autism Allergy
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Vaccine Demand Share Forecast, 2019-2026
9. Latin America Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Vaccine Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Vaccine Market Size and Volume Forecast by Types
9.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Vaccine Market Size and Volume Forecast by Applications
9.7.1. Infectious Diseases Cancer Autism Allergy
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Vaccine Demand Share Forecast, 2019-2026
10. Europe Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Vaccine Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Vaccine Market Size and Volume Forecast by Types
10.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Vaccine Market Size and Volume Forecast by Applications
10.7.1. Infectious Diseases Cancer Autism Allergy
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Vaccine Demand Share Forecast, 2019-2026
11. Asia Pacific Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Vaccine Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Vaccine Market Size and Volume Forecast by Types
11.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Vaccine Market Size and Volume Forecast by Applications
11.7.1. Infectious Diseases Cancer Autism Allergy
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Vaccine Demand Share Forecast, 2019-2026
12. Middle East & Africa Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Vaccine Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Vaccine Market Size and Volume Forecast by Types
12.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Vaccine Market Size and Volume Forecast by Applications
12.7.1. Infectious Diseases Cancer Autism Allergy
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Vaccine Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Vaccine Market: Market Share Analysis
13.2. Vaccine Distributors and Customers
13.3. Vaccine Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Merck &Co., Inc. Emergent BioSolutions, Inc. Johnson and Johnson Sanofi Pasteur, Inc. Pfizer, Inc. Novartis AG
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vaccine Market - Supply Chain
4.5. Global Vaccine Market Forecast
4.5.1. Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vaccine Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Vaccine Market Absolute $ Opportunity
5. Global Vaccine Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Vaccine Market Size and Volume Forecast by Types
5.3.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Vaccine Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Vaccine Market Size and Volume Forecast by Applications
6.3.1. Infectious Diseases Cancer Autism Allergy
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Vaccine Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Vaccine Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Vaccine Demand Share Forecast, 2019-2026
8. North America Vaccine Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Vaccine Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Vaccine Market Size and Volume Forecast by Types
8.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Vaccine Market Size and Volume Forecast by Applications
8.7.1. Infectious Diseases Cancer Autism Allergy
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Vaccine Demand Share Forecast, 2019-2026
9. Latin America Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Vaccine Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Vaccine Market Size and Volume Forecast by Types
9.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Vaccine Market Size and Volume Forecast by Applications
9.7.1. Infectious Diseases Cancer Autism Allergy
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Vaccine Demand Share Forecast, 2019-2026
10. Europe Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Vaccine Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Vaccine Market Size and Volume Forecast by Types
10.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Vaccine Market Size and Volume Forecast by Applications
10.7.1. Infectious Diseases Cancer Autism Allergy
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Vaccine Demand Share Forecast, 2019-2026
11. Asia Pacific Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Vaccine Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Vaccine Market Size and Volume Forecast by Types
11.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Vaccine Market Size and Volume Forecast by Applications
11.7.1. Infectious Diseases Cancer Autism Allergy
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Vaccine Demand Share Forecast, 2019-2026
12. Middle East & Africa Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Vaccine Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Vaccine Market Size and Volume Forecast by Types
12.4.1. Live Attenuated Vaccines Inactivated Vaccines Subunit Vaccines
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Vaccine Market Size and Volume Forecast by Applications
12.7.1. Infectious Diseases Cancer Autism Allergy
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Vaccine Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Vaccine Market: Market Share Analysis
13.2. Vaccine Distributors and Customers
13.3. Vaccine Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Merck &Co., Inc. Emergent BioSolutions, Inc. Johnson and Johnson Sanofi Pasteur, Inc. Pfizer, Inc. Novartis AG
Our Clients
Related Reports
Some other reports from this category!
